Injection of a CD44 mAb-IR700 dye conjugate (anti-CD44-IR700) in mice bearing oral SCC CD44+ MOC1 and MOC2 tumors significantly inhibited tumor growth and prolonged survival [142]. This evidence concerns the gene CD44 and neoplasm.